Estimating background rates of Guillain-Barr-Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign
- Small risk of Guillain-BarrÃ© syndrome with H1N1 2009 vaccines. // Reactions Weekly;03/23/2013, Issue 1445, p2
The article reports that according to the results of a large meta-analysis in the U.S., influenza A (H1N1) 2009 monovalent inactivated vaccines contributed in slightly increasing the risk of Guillain-Barr'e syndrome (GBS).
- Slight risk for Guillain-BarrÃ© syndrome attributed to HIN1 vaccine. // Infectious Disease News;Apr2013, Vol. 26 Issue 4, p25
The article discusses the results of a study conducted by Dr. Bruce Gellin and colleagues and published in the "Lancet" journal regarding the association between the development of Guillain-BarrÃ© syndrome and the administration of influenza A (H1N1) 2009 monovalent inactivated vaccine.
- HIN1 vaccine given to pregnant women not linked to GBS, poor birth outcomes. // Infectious Disease News;Aug2012, Vol. 25 Issue 8, p28
The article discusses the two separate studies that contrasts findings regarding the safety of influenza A(H1N1) vaccine given to pregnant women and risk of Guillain-BarrÃ© syndrome (GBS) among adults.
- H1N1 immunisation: too much too soon? COLLIGNON, PETER // Natural Health & Vegetarian Life;Winter2010, p34
In this article, the author comments on the risks and adverse effects of H1N1 vaccination prompted by the swine flu outbreak in Australia in the winter of 2009. It discusses the findings of an Australian H1N1 vaccine trial of adults indicating that more than half of the Australian population are...
- H1N1 vaccination does not increase risk of relapse in multiple sclerosis: a self-controlled case-series study. Farez, Mauricio F; Ysrraelit, Mar�a C; Fiol, Marcela; Correale, Jorge // Multiple Sclerosis Journal;Feb2012, Vol. 18 Issue 2, p254
The article discusses the study on the effects of the H1N1 influenza vaccines in patients with multiple sclerosis (MS). It states that there was no association between H1N1 immunization and increased exacerbation rate in MS which was the conclusion of the study. It discusses H1N1 influenza...
- Monitoring Adverse Events of the Vaccination Campaign Against Influenza A (H1N1) in the Netherlands. van Puijenbroek, Eugène P.; Broos, Nancy; van Grootheest, Kees // Drug Safety;2010, Vol. 33 Issue 12, p1097
Background: In November 2009, a vaccination campaign against Influenza A (H1N1) was started in the Netherlands. The accelerated registration procedure of the vaccines used in this campaign and the use of these vaccines on a large scale indicated a need for real-time safety monitoring. Objective:...
- The Safety of H1N1 Vaccine in Children in Saudi Arabia: A Cohort Study Using Modem Technology in a Developing Country. Aljadhey, Hisham; Alyabsi, Mesnad; Alrwisan, Adel; Alqahtani, Nasser; Almutairi, Reem; Al Tawil, Esraa; Adam, Mansour; Shakir, Saad; Aljeraisy, Majed; Al-Blowi, Ali; Alkhashan, Hesham; Albogami, Yasser; Murray, Michael D. // Drug Safety;2012, Vol. 35 Issue 7, p555
Background: With its rapid introduction in 2009, concerns about the safety of the H1N1 vaccines have been raised. Data were especially limited on the pediatric safety of H1N1 vaccine in Saudi Arabia. Objectives: The objectives of this study were to investigate the safety of the H1N1 vaccine...
- Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials. Mallory, Raburn M.; Malkin, Elissa; Ambrose, Christopher S.; Bellamy, Terramika; Shi, Li; Yi, Tingting; Jones, Taff; Kemble, George; Dubovsky, Filip // PLoS Clinical Trials;Oct2010, Vol. 7 Issue 10, Special section p1
Background: The safety, tolerability, and immunogenicity of a monovalent intranasal 2009 A/H1N1 live attenuated influenza vaccine (LAIV) were evaluated in children and adults. Methods/Principal Findings: Two randomized, double-blind, placebo-controlled studies were completed in children (2-17 y)...
- Influenza vaccination: lessons learned from the pandemic (H1N1) 2009 influenza outbreak. Openshaw, P J M; Dunning, J // Mucosal Immunology (1933-0219);Sep2010, Vol. 3 Issue 5, p422
In this article the authors discuss the lessons that they have learned during the outbreak of the pandemic (H1N1) influenza virus on 2009. The authors discover that the virus is only a mild infection which brought severe diseases to people due to the combination of host genotype and the virus...